Angiotensin receptor blockers in acute myocardial infarction

By Salam Amar M  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 4, 2004-04 ,pp. : 427-430

Informa Healthcare

Access to resources Recommend Favorite

AT₁ Receptor Blockade Prevents Cardiac Dysfunction after Myocardial Infarction in Rats

By Berthonneche Corinne   Sulpice Thierry   Tanguy Stéphane   O’Connor Stephen   Herbert Jean-Marc   Janiak Philippe   Leiris Joël   Boucher François  

Cardiovascular Drugs and Therapy, Vol. 19, Iss. 4, 2005-08 ,pp. : 251-259

Springer Publishing Company

Access to resources Recommend Favorite

Effects of a novel angiotensin AT 1 receptor antagonist, HR720, on rats with myocardial infarction

By Xia Q.-G.   Chung O.   Spitznagel H.   Sandmann S.   Illner S.   Rossius B.   Jahnichen G.   Reinecke A.   Gohlke P.   Unger T.  

European Journal of Pharmacology, Vol. 385, Iss. 2, 1999-12 ,pp. : 171-179

Elsevier

Access to resources Recommend Favorite

Clinical trials evaluating angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the setting of acute myocardial infarction

By Salam Amar M  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 3, 2003-03 ,pp. : 501-507

Informa Healthcare

Access to resources Recommend Favorite

Importance of potent P2Y₁₂ receptor blockade in acute myocardial infarction: focus on prasugrel

By Jeong Young-Hoon   Tantry Udaya S   Gurbel Paul A  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 12, 2012-08 ,pp. : 1771-1796

Informa Healthcare

Access to resources Recommend Favorite